NDC 51808-214
Exametazime HMPAO
Exametazime
Exametazime HMPAO is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Exametazime.
Product ID | 51808-214_dd2d8053-37a4-465d-9086-2bd084c4898c |
NDC | 51808-214 |
Product Type | Human Prescription Drug |
Proprietary Name | Exametazime HMPAO |
Generic Name | Exametazime |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2012-07-01 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | EXAMETAZIME |
Active Ingredient Strength | 1 mg/1 |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |